SCNI
Scinai Immunotherapeutics Ltd.
There isn't enough reported data to score SCNI yet.
SCNI Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate SCNI's fundamentals.
SCNI PE Valuation
SCNI has no meaningful PE right now: it lost money over the past year.
SCNI Forward outlook
There aren't enough analyst estimates for SCNI to show an outlook.
SCNI Earnings Per Share
SCNI Quarterly Revenue
SCNI Free Cash Flow
SCNI Total Shares
SCNI Net Leverage
SCNI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SCNI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 24.5 | Oversold |
| Stochastic | 1.1 | Oversold |
SCNI's weekly RSI is 25 (oversold) and its Stochastic is 1 (oversold).
SCNI PE vs Healthcare Sector
SCNI has no meaningful PE right now: it lost money over the past year.
SCNI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.84 | 48% below |
| 20 week MA | $1.76 | 75% below |
| 50 week MA | $4.85 | 91% below |
| 100 week MA | $14.1 | 97% below |
| 200 week MA | $54.2 | 99% below |
SCNI is in a downtrend: it's below all five of its weekly moving averages, and 99% below its 200-week average.
SCNI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8,300.0 | $3,170.0 | -62% |
| 2021 | $3,170.0 | $2,780.0 | -12% |
| 2022 | $2,780.0 | $326.0 | -88% |
| 2023 | $326.0 | $59.5 | -82% |
| 2024 | $59.5 | $33.4 | -44% |
| 2025 | $33.4 | $7.04 | -79% |
| 2026 YTD | $7.04 | $0.44 | -94% |
SCNI has finished every year since 2020 lower, and it's down 94% so far in 2026.